Mojave Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
To improve antigen recognition, Mojave Therapeutics is harnessing the intracellular antigenic peptide chaperone function of heat shock proteins. It has created a universal cassette for antigen delivery using hsp's, which it calls Javelin technology, that is applicable for active immunotherapy of infectious diseases and cancer.